0001522727false00015227272026-09-032026-09-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
September 3, 2026
Date of report (Date of earliest event reported)
USA Compression Partners, LP
(Exact Name of Registrant as Specified in its charter) | | | | | | | | | | | | | | |
| Texas | | 1-35779 | | 75-2771546 |
| (State or other jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
8117 Preston Road, Suite 300
Dallas, Texas 75225
(Address of principal executive offices) (zip code)
(214) 545-0440
(Registrant’s telephone number, including area code)
8115 Preston Road, Suite 700
Dallas, Texas 75225
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol(s) | | Name of exchange on which registered |
| Common units representing limited partner interests | | USAC | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On September 3, 2026, USA Compression Partners, LP (the “Partnership”) approved the voluntary withdrawal of its common units representing limited partner interests (the “Common Units”) from listing on the New York Stock Exchange (“NYSE”), and the transfer of that listing to the Texas Stock Exchange (“TXSE”). The Partnership expects that the listing and trading of the Common Units on the NYSE will end at market close on October 2, 2026, and that trading will begin on the TXSE at market open on October 5, 2026. The ticker symbol for the Common Units (TXSE: USAC) will remain unchanged.
Item 7.01 Regulation FD Disclosure.
On September 10, 2026, the Partnership issued the press release attached hereto as Exhibit 99.1 in connection with the transfer of the listing of the Common Units from NYSE to TXSE.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document.
Item 9.01 Financial Statements and Exhibits.
| | | | | | | | | | |
| Exhibit Number | | Exhibit Description | | |
| | | | |
| 99.1 | | | | |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | |
| | USA COMPRESSION PARTNERS, LP |
| | | |
| | By: | USA Compression GP, LLC, |
| | | its General Partner |
| | | |
| Date: | September 10, 2026 | By: | /s/ Christopher W. Porter |
| | | Christopher W. Porter |
| | | Senior Vice President, General Counsel and Secretary |